Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- ANGSTROM RESOLUTION;; CRYSTAL-STRUCTURE;; SUBUNIT;; COMPLEX;; Biochemistry & Molecular Biology;; Cell Biology (1)
- Acetylation/drug effects;; Animals;; Comparative Genomic Hybridization;; Diet (1)
- Acquired aplastic anemia;; diagnosis;; NAPAAC;; treatment;; IMMUNOSUPPRESSIVE THERAPY;; ANTITHYMOCYTE GLOBULIN;; STIMULATING FACTOR;; CHILDREN;; EPIDEMIOLOGY;; CHILDHOOD;; TRANSPLANTATION;; CYCLOSPORINE;; MULTICENTER;; EXPERIENCE;; Oncology;; Hematology;; Pediatrics (1)
- Adolescent;; Antirheumatic Agents/adverse effects/ therapeutic use;; Arthritis (1)
- Adolescent;; Apolipoprotein A-I/ genetics;; Case-Control Studies;; Child;; Cohort Studies;; Colitis (1)
-
- Adolescent;; Biological Markers/metabolism;; Calgranulin B/genetics/metabolism;; Child;; Child (1)
- Advisory Committees;; Anti-Infective Agents/therapeutic use;; Bacterial Capsules;; Centers for Disease Control and Prevention (U.S.);; Chemoprevention/standards;; Child (1)
- Advisory Committees;; Humans;; Immunization/ standards;; Immunization Schedule;; Infant;; Licensure;; Meningococcal Infections/ prevention & control;; Meningococcal Vaccines/ administration & dosage;; Practice Guidelines as Topic;; Randomized Controlled Trials as Topic;; Risk Assessment;; United States (1)
- Algorithms;; Female;; Genetic Testing/methods;; Humans;; Immunophenotyping/methods;; Infant (1)
- Anemia (1)
- Animal;; Pregnancy;; Prenatal Exposure Delayed Effects/ genetics;; Prenatal Nutritional Physiological Phenomena/ genetics;; Glut4;; H3K14ac;; H3K9me3;; developmental origin (1)
- Antigen (1)
- Arterial blood;; oxygen saturation;; photoplethysmography;; pulse oximetry;; venous blood (1)
- Avoidant/Restrictive food intake disorder (ARFID);; Children and;; adolescents;; 5th Edition of the diagnostic and statistical Manual;; (DSM-5);; Anorexia nervosa (AN);; Bulimia nervosa (BN);; EATING-DISORDERS;; CHILDHOOD;; CLASSIFICATION;; CRITERIA;; Psychology (1)
- CD4(+) T-CELLS;; DENDRITIC CELLS;; INTERLEUKIN-1 FAMILY;; SKIN;; INFLAMMATION;; DISEASE SEVERITY;; IN-VIVO;; EXPRESSION;; TOLERANCE;; IL-36;; SUPPRESSION;; Biochemistry & Molecular Biology;; Cell Biology;; Medicine (1)
- Celecoxib;; Juvenile idiopathic arthritis;; NSAIDs;; Safety (1)
- Child (1)
- Childhood nephrotic syndrome;; Frequent-relapse steroid-sensitive nephrotic syndrome;; Rituximab;; Second-line immunosuppressive treatment;; Steroid-dependent nephrotic syndrome;; Steroid-resistant nephrotic syndrome;; Tacrolimus (1)
- Cohort Studies (1)
- Crohn’s disease;; Inflammatory bowel disease;; immunization;; immunosuppression;; ulcerative colitis;; vaccine (1)
- DNA (1)
- Developmental/drug effects;; Genetic Predisposition to Disease;; Glucose Transporter Type 4/genetics;; Histone Code/ drug effects/genetics;; Histones/ genetics;; Liver/ embryology/enzymology;; Metabolic Syndrome X/genetics;; Mice;; Models (1)
- Developmental;; Public (1)
- Dexamethasone;; betamethasone;; bronchopulmonary dysplasia;; cytokines;; phagocytosis;; respiratory burst;; HYALINE-MEMBRANE DISEASE;; CHRONIC LUNG-DISEASE;; BRONCHOPULMONARY;; DYSPLASIA;; PRETERM INFANTS;; CYTOKINE RELEASE;; PULMONARY-HYPERTENSION;; ALVEOLAR MACROPHAGES;; DEXAMETHASONE;; EXPRESSION;; NEWBORN;; Obstetrics & Gynecology;; Pediatrics (1)
- Dose-Response Relationship (1)
- Drug (1)
- EXTREMELY PREMATURE-INFANTS;; NECROTIZING ENTEROCOLITIS;; NEONATAL SEPSIS;; WEIGHT INFANTS;; COSTS;; RISK;; Obstetrics & Gynecology;; Pediatrics (1)
- Environmental & Occupational Health;; Pediatrics (1)
- Exome (1)
- Female;; Humans;; Incidence;; Infant (1)
Articles 31 - 35 of 35
Full-Text Articles in Medicine and Health Sciences
Critical Periods Of Increased Fetal Vulnerability To A Maternal High Fat Diet, M. D. Plata, L. Williams, Y. Seki, K. Hartil, H. Kaur, C. L. Lin, A. Fiallo, A. S. Glenn, E. B. Katz, P. M. Vuguin, +2 Additional Authors
Critical Periods Of Increased Fetal Vulnerability To A Maternal High Fat Diet, M. D. Plata, L. Williams, Y. Seki, K. Hartil, H. Kaur, C. L. Lin, A. Fiallo, A. S. Glenn, E. B. Katz, P. M. Vuguin, +2 Additional Authors
Journal Articles
Background: Fetal adaptations to high fat (HF) diet in utero (IU) that may predispose to Metabolic Syndrome (MetS) in adulthood include changes in fetal hepatic gene expression. Studies were performed to determine whether maternal exposure to HF diet at different stages during pregnancy had different effects on the fetus, including hepatic gene expression. Methods: Female wild type mice were fed either a HF or breeding chow (C) for 2 wks prior to mating. The experimental groups were composed of embryonic day (e) 18.5 fetuses obtained from WT female mice that were fed HF (HF, 35.5% fat) or breeding chow (C, …
Randomized, Double-Blind, Placebo-Controlled Trial Of The Efficacy And Safety Of Rilonacept In The Treatment Of Systemic Juvenile Idiopathic Arthritis, N. T. Ilowite, K. Prather, Y. Lokhnygina, L. E. Schanberg, M. Elder, D. Milojevic, J. W. Verbsky, S. J. Spalding, B. S. Gottlieb, C. I. Sandborg, +12 Additional Authors
Randomized, Double-Blind, Placebo-Controlled Trial Of The Efficacy And Safety Of Rilonacept In The Treatment Of Systemic Juvenile Idiopathic Arthritis, N. T. Ilowite, K. Prather, Y. Lokhnygina, L. E. Schanberg, M. Elder, D. Milojevic, J. W. Verbsky, S. J. Spalding, B. S. Gottlieb, C. I. Sandborg, +12 Additional Authors
Journal Articles
OBJECTIVE: To assess the efficacy and safety of rilonacept, an interleukin-1 inhibitor, in a randomized, double-blind, placebo-controlled trial. METHODS: An initial 4-week double-blind placebo phase was incorporated into a 24-week randomized multicenter design, followed by an open-label phase. Seventy-one children who had active arthritis in >/=2 joints were randomized (1:1) to the 2 arms of the study. Patients in the rilonacept arm received rilonacept (loading dose 4.4 mg/kg followed by 2.2 mg/kg weekly, subcutaneously) beginning on day 0. Patients in the placebo arm received placebo for 4 weeks followed by a loading dose of rilonacept at week 4 followed by …
Second-Line Immunosuppressive Treatment Of Childhood Nephrotic Syndrome: A Single-Center Experience, J. Kim, N. Patnaik, N. Chorny, R. Frank, L. Infante, C. Sethna
Second-Line Immunosuppressive Treatment Of Childhood Nephrotic Syndrome: A Single-Center Experience, J. Kim, N. Patnaik, N. Chorny, R. Frank, L. Infante, C. Sethna
Journal Articles
OBJECTIVE: Most cases of idiopathic nephrotic syndrome in childhood are responsive to corticosteroids. However, there is a small group of children that demonstrate steroid resistance (steroid-resistant nephrotic syndrome; SRNS), steroid dependence, or that frequently relapse (frequent-relapse steroid-sensitive nephrotic syndrome; FR-SSNS) which are more clinically difficult to treat. Therefore, second-line immunosuppressants, such as alkylating agents, calcineurin inhibitors, antimetabolites and, more recently, rituximab, have been used with varying success. The objective was to evaluate the response rates of various second-line therapies in the treatment of childhood nephrotic syndrome. STUDY DESIGN: A retrospective chart review of pediatric subjects with idiopathic nephrotic syndrome was …
A New System For Naming Ribosomal Proteins, N. Ban, R. Beckmann, J. H. D. Cate, J. D. Dinman, F. Dragon, S. R. Ellis, D. L. J. Lafontaine, L. Lindahl, J. M. Lipton, M. Yusupov, +15 Additional Authors
A New System For Naming Ribosomal Proteins, N. Ban, R. Beckmann, J. H. D. Cate, J. D. Dinman, F. Dragon, S. R. Ellis, D. L. J. Lafontaine, L. Lindahl, J. M. Lipton, M. Yusupov, +15 Additional Authors
Journal Articles
A system for naming ribosomal proteins is described that the authors intend to use in the future. They urge others to adopt it. The objective is to eliminate the confusion caused by the assignment of identical names to ribosomal proteins from different species that are unrelated in structure and function. In the system proposed here, homologous ribosomal proteins are assigned the same name, regardless of species. It is designed so that new names are similar enough to old names to be easily recognized, but are written in a format that unambiguously identifies them as 'new system' names.
Decreased Langerhans Cell Responses To Il-36 Gamma: Altered Innate Immunity In Patients With Recurrent Respiratory Papillomatosis, J. Devoti, L. Hatam, A. Lucs, A. Afzal, A. Abramson, B. M. Steinberg, V. Bonagura
Decreased Langerhans Cell Responses To Il-36 Gamma: Altered Innate Immunity In Patients With Recurrent Respiratory Papillomatosis, J. Devoti, L. Hatam, A. Lucs, A. Afzal, A. Abramson, B. M. Steinberg, V. Bonagura
Journal Articles
Recurrent respiratory papillomatosis (RRP) is a rare, chronic disease caused by human papillomaviruses (HPVs) types 6 and 11 that is characterized by the polarization of adaptive immune responses that support persistent HPV infection. Respiratory papillomas express elevated mRNA levels of IL-36 gamma, a proinflammatory cytokine in comparison to autologous clinically normal laryngeal tissues; however there is no evidence of inflammation in these lesions. Consistent with this, respiratory papillomas do not contain T(H)1-like CD4(+) T-cells or cytotoxic CD8(+) T-cells, but instead contain a predominance of T(H)2-like and T regulatory cells (Tregs). In addition, papillomas also are infiltrated with immature Langerhans cells …